Skip to content
  • Latest Posts
    • Latest Medical News
    • M3 Recommends
    • Mental Health and Well-Being
    • M3 Pulse
    • M3 Health Talks
    • M3 Survey Insights
    • Physician Hub
    • Oncology Focus
  • Healthcare Market Research
    • How To Participate In Healthcare Market Research?
    • What is Healthcare Market Research? Benefits and Methods
    • Why Participate in Healthcare Market Research?
    • Available Medical Studies
  • M3 Difference
    • QualStage
    • M3 Daily Digests
    • M3 Wallet
    • M3 Profile
    • M3 Prepaid Cards
    • M3 Referral Programme
    • Case Studies
  • Partners
    • Meet Our Ambassadors
    • Associations
  • Contact Us
  • Latest Posts
    • Latest Medical News
    • M3 Recommends
    • Mental Health and Well-Being
    • M3 Pulse
    • M3 Health Talks
    • M3 Survey Insights
    • Physician Hub
    • Oncology Focus
  • Healthcare Market Research
    • How To Participate In Healthcare Market Research?
    • What is Healthcare Market Research? Benefits and Methods
    • Why Participate in Healthcare Market Research?
    • Available Medical Studies
  • M3 Difference
    • QualStage
    • M3 Daily Digests
    • M3 Wallet
    • M3 Profile
    • M3 Prepaid Cards
    • M3 Referral Programme
    • Case Studies
  • Partners
    • Meet Our Ambassadors
    • Associations
  • Contact Us
Join

Technology in Healthcare 2020 – A Comparison

  • M3 Insights
  • October 26, 2020
The ‘New Normal’ in America includes working remotely and seeing loved ones and others through the aid of a computer or phone screen.

To provide Americans with healthcare while keeping coronavirus risk as low as possible, many healthcare facilities implemented telehealth options for their staff and patients.

We asked our panel communities of healthcare professionals and patients to share their opinion about telehealth. Please see key highlights of the 2 surveys below.

To see full results from our survey of healthcare professionals, please click here.

To see full results from our survey of patients, please click here.

Have your voice heard on relevant healthcare topics.

Join today and take part in paid market research studies!

Healthcare professional
OR
General Public/Caregiver

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Join Today

Registration is free and only takes a few clicks
Sign Up

Panel Members

Check your available studies
Log in

latest posts

Pseudomonas aeruginosa may be a more common cause of Urinary Tract Infections (UTIs) than expected, according to new research published in mSphere.

Study Highlights Emerging Bacterial Cause of Urinary Tract Infections

August 3, 2026

Study finds Pseudomonas aeruginosa causes 4% of UTIs along US Gulf Coast, nearly double national average, with concerning antibiotic resistance patterns.

Vaccines for Zaire ebolavirus may also protect against Bundibugyo Virus, suggesting existing Ebola Vaccine stockpiles could aid outbreak response.

Licensed Ebola Vaccines Trigger Cross-Reactive Antibodies Against Bundibugyo Virus

August 3, 2026

Vaccines for Zaire ebolavirus may also protect against Bundibugyo Virus, suggesting existing Ebola Vaccine stockpiles could aid outbreak response.

New research finds glp-1 medications like semaglutide for type 2 diabetes may boost physical health, but not mental or social outcomes.

Study Finds Limited Evidence That GLP-1 Medications Improve Mental Health or Social Outcomes

August 3, 2026

New research finds GLP-1 drugs like semaglutide for type 2 diabetes may improve physical health, but not mental or social outcomes.

Page1 Page2 Page3 Page4 Page5

Join Today

  • By joining M3 Global Research, you can start participating in paid online surveys, interviews, discussion forums, and other exclusive opportunities for members.
  • Already a member? Login here.
Sign Up and Start Earning Today

The M3 Difference

  • About M3 Global Research
  • M3 Daily Digests
  • M3 Wallet
  • M3 Dynamic Profile
  • M3 Prepaid Cards
  • Case Studies

Contact

  • If you have any questions, please contact our Support Team.
Get In Touch

© 2026 M3 Global Research. A Division of M3 Inc. All Rights Reserved.

Privacy Policy

Facebook-f Twitter Youtube Instagram Linkedin-in